Question Number 3: A new drug is proposed to lower total cholesterol and a study is designed to evaluate the efficacy of the drug in lowering cholesterol. Fifteen patients agree to participate in the study and each is asked to take the new drug for 6 weeks. However, before starting the treatment, each patient's total cholesterol level is measured. The initial measurement is a pre-treatment or baseline value. After taking the drug for 6 weeks, each patient's total cholesterol level is measured again and the data are shown below. Subject Identification Number Baseline 6 Weeks 1 215 205 2 190 156 3 230 190 4 220 180 5 214 201 6 240 227 7 210 197 8 193 173 9 210 204 10 230 217 11 180 142 12 260 262 13 210 207 14 190 184 15 200 193 Is there statistical evidence of a reduction in mean total cholesterol in patients after using the new medication for 6 weeks?
First of all note that the data has been collected on the same set of people before and after treatment with new drug. As the data has been collected using repeated samples, so the data is paired and thus we would use a paired sample t-test.
As we want to test if the drug has reduced the mean cholestrol in patients, so we would want the mean of differences for population to be positive such that the data before treatment are higher than post treatment.
Define and as the population mean cholestrol level before and after administration of drug into the body respectively. And let be the difference -
So, the hypothesis would be lower tailed written as -
Null Hypothesis - H0:
Alternate Hypothesis - H1:
Now, create a separate column for difference between the values of 'Baseline' and '6 Weeks After' as shown -
Identification Number | Baseline (X1i) | 6 Weeks after (X2i) | Difference (di) |
1 | 215 | 205 | 10 |
2 | 190 | 156 | 34 |
3 | 230 | 190 | 40 |
4 | 220 | 180 | 40 |
5 | 214 | 201 | 13 |
6 | 240 | 227 | 13 |
7 | 210 | 197 | 13 |
8 | 193 | 173 | 20 |
9 | 210 | 204 | 6 |
10 | 230 | 217 | 13 |
11 | 180 | 142 | 38 |
12 | 260 | 262 | -2 |
13 | 210 | 207 | 3 |
14 | 190 | 184 | 6 |
15 | 200 | 193 | 7 |
Now, you can either use excel to directly get the test result or you can do it manually.
1) Using Excel
Use excel's 'Data Analysis' add-on under the 'Data' tab to access the 't-Test: Paired Two Sample for Means' as shown -
Then in the next prompt box, enter the variable ranges as the 'Baseline' and '6 Weeks Later' data. As the hypothesized mean difference is '0', so put the same in prompt. Also make sure to mark the 'Labels' option as we have label in our first row. Your input should look similar to this -
Note that you can set level of significance as per your needs. By default its chosen as 0.05.
This should give you following result -
t-Test: Paired Two Sample for Means | ||
Baseline | 6 Weeks after | |
Mean | 212.8 | 195.8666667 |
Variance | 450.8857143 | 824.2666667 |
Observations | 15 | 15 |
Pearson Correlation | 0.881282389 | |
Hypothesized Mean Difference | 0 | |
df | 14 | |
t Stat | 4.630004243 | |
P(T<=t) one-tail | 0.000194797 | |
t Critical one-tail | 1.761310136 | |
P(T<=t) two-tail | 0.000389595 | |
t Critical two-tail | 2.144786688 | |
As we had a one-tailed test, so note that the p-value for a one tailed test = 0.000194797 0.0002
As the p-value is less than the significance level, so we reject the null hypothesis and conclude that there is enough evidence to support the claim that the cholestrol level has decreased 6 weeks after administration of drug in the body.
__________________________________________________
Solving it manually -
Calculate the sample mean differences and standard deviation of differences using formula -
You can calculate the values as -
Identification Number | Baseline (X1i) | 6 Weeks after (X2i) | Difference (di) | ||
1 | 215 | 205 | 10 | -6.93333 | 48.07111 |
2 | 190 | 156 | 34 | 17.06667 | 291.2711 |
3 | 230 | 190 | 40 | 23.06667 | 532.0711 |
4 | 220 | 180 | 40 | 23.06667 | 532.0711 |
5 | 214 | 201 | 13 | -3.93333 | 15.47111 |
6 | 240 | 227 | 13 | -3.93333 | 15.47111 |
7 | 210 | 197 | 13 | -3.93333 | 15.47111 |
8 | 193 | 173 | 20 | 3.066667 | 9.404444 |
9 | 210 | 204 | 6 | -10.9333 | 119.5378 |
10 | 230 | 217 | 13 | -3.93333 | 15.47111 |
11 | 180 | 142 | 38 | 21.06667 | 443.8044 |
12 | 260 | 262 | -2 | -18.9333 | 358.4711 |
13 | 210 | 207 | 3 | -13.9333 | 194.1378 |
14 | 190 | 184 | 6 | -10.9333 | 119.5378 |
15 | 200 | 193 | 7 | -9.93333 | 98.67111 |
Sum | 254 | 2808.933 |
Then the test statistic is -
So, we get -
The degree of freedom of test = n-1 = 15 - 1 = 14
Significance level = = 0.05
So, critical value of test statistic = t0.05,14 = 1.761
As calculated value of test statistic = 4.63 > critical value of test statistic = 1.761, so we reject the null hypothesis and conclude that there is enough evidence in the data to support the claim that the mean cholestrol of population decreases after 6 weeks of administration of drug into body.
____________________________________________
Please ask if you have any doubt(s) in comment section.
____________________________________________________________________
Question Number 3: A new drug is proposed to lower total cholesterol and a study is...
(1 point) A new drug to lower total cholesterol is being tested. A study is designed to evaluate the efficacy of the drug. Sixteen patients agree to participate in the study and each is asked to take the new drug for 4 weeks. Before starting the treatment, each patient's total cholesterol level is measured. After taking the drug for 4 weeks, each patient's total cholesterol level is measured again. The 99% confidence interval for the change in total cholesterol (After...
A study is run to estimate the mean total cholesterol level in children 2-6 years of age. A sample of 13 participants is selected and their total cholesterol levels are measured as follows. 170 185 225 240 196 175 180 194 147 223 240 220 210 a) Assume the mean total cholesterol level is 190 in children 2-6 years of age at national level. Test whether the cholesterol level in this sample is significantly different from national level. b) Generate...
1) Investigators want to determine the effectiveness of a new drug in lowering cholesterol. They conduct a small clinical trial in which patients were randomized to receive the new drug or placebo. The total cholesterol was measured after ten weeks on the assigned treatment. The table below shows the results. Sample Size (n) Mean Cholesterol SD New drug 30 198.8 26.7 Placebo 30 215.4 30.3 Is there sufficient evidence to conclude a difference in mean cholesterol for patients on the...
Investigators want to determine the effectiveness of a new drug in lowering cholesterol. They conduct a small clinical trial in which patients were randomized to receive the new drug or placebo. The total cholesterol was measured after ten weeks on the assigned treatment. The table below shows the results. Sample size (n) Mean Clostrol SD New drug 30 198.8 26.7 Placebo 30 215.4 30.3 Is there sufficient evidence to conclude a difference in mean cholesterol for patients on the...
In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug for treating a disease wants to investigate the effectiveness of this generic drug as compared to the traditional brand name drug, At the present time, the brand name drug is the only approved treatment for the disease. Patients diagnosed with the disease have low concentration of a specific factor in their blood. Treatment with the brand name drug will result in an increase in...
3. The following contingency table represents a study to determine if a new drug is effective in treating lower back pain. Participants were asked their pain levels two weeks after taking the two different treatments. No Pain Moderate Pain High Pain Drug 36 131 82 Placebo 12 194 157 a. How many of the patients had no pain or took the drug? (5) b. What percent of the patients had a high pain level? (5) c. What percent of the...
5. A study is planned to assess the effectiveness of a new combination drug for treating nephrolithiasis (kidney stone). One hundred patients with nephrolithiasis will be randomly assigned to receive either the new combination drug or the standard surgical intervention. The efficacy of the new drug will be measured by the time it takes a patient to return to normal activities, measured in days. Identify the appropriate research design for this study a. Prospective cohort study b. Randomized controlled trial...
6) It has been study. One een levels of treatment for the new drug will be used in the 2 study. One group will be administered the new phase of the drug once per day and a second group twice per day. You select two SRSs of 19 and 21 individuals who have been diagnosed as having high n diagnosed adrug twice per administered the new drug once per dayad cholest total cholesterol. Results are summarized in the table below....
13. The data in Table 6-27 are collected in a randomized trial to test the efficacy of a new drug for migraine headaches. The following are characteristics of study participants overall and then organized by the treatment to which they are assigned TABLE 6-27Characteristics in Participants in Study of Treatment for Migraine Headaches All (n- 200) Placebo (n 100) New Drug (n 100) 32.0 (4.9) 31.9 (5.1) 32.8 (4.7 Mean (SD) age, years 51% 48% 54% % Male 78% 80%...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)−(blood pressure after taking new drug). Use a significance level of α=0.1 for the test. Assume that the systolic blood pressure levels are normally...